CFRA Downgrades View On Shares Of Nucor Corporation To Sell From Hold

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our 12-month target by $11 to $167, which assumes an EV/EBITDA of 7.5x our ’24 EBITDA estimate, a premium to NUE’s three-year avg. forward EV/EBITDA of 5.5x and above peers’ avg. forward EV/EBITDA of 6.6x. We raise our ’24 EPS estimate by $0.54 to $12.87 and initiate our ’25 EPS forecast at $12.10. NUE posts Q4 adj. EPS of $3.16 vs. $4.89, $0.33 above consensus, with in-line sales. Q4 avg. sales price fell 15% Y/Y but shipment volume rose 8% Y/Y. NUE is facing some very difficult comps in ’24 and we forecast a decline in adj. EPS of 28% in ’24 and 6% in ’25 (and adj. EBITDA declines of 23% in ’24 and 3% in ’25). NUE currently trades at a significant premium to its historical average (51% premium to its three-year avg. forward EV/EBITDA) and a 26% premium relative to peers. We recognize secular tailwinds from onshoring of manufacturing and strong infrastructure demand, but we are concerned that Y/Y declines in adj. EPS throughout ’24 will lead to earnings multiple contraction.

Scroll to Top